Saad Abu Zahra

Dr. Saad Abu Zahra


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SZSaad Abu Zahra
Saad Abu Zahra
ANArsalan Nadeem
Arsalan Nadeem
AKAshima Kundu
Ashima Kundu
NGNick Gibson
Nick Gibson
AHAli Haggaz
Ali Haggaz
AGAndrew C. Gordon
Andrew C. Gordon
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with curative surgical interventions feasible for a minority of patients. This review highlights recent advances in thermal (e.g., radiofrequency ablation, microwave ablation, and cryoablation) and nonthermal (e.g., ethanol ablation and irreversible electroporation) ablative modalities as curative-intent alternatives to surgery. Evolving applications of transcatheter intra-arterial radioembolization (TARE) with ablative dosimetry will be explored, and histotripsy, an emerging technology, will be introduced.

11 September 2026 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
AGAndrew C. Gordon
Andrew C. Gordon
SZSaad Abu Zahra
Saad Abu Zahra
ABAmir A. Borhani
Amir A. Borhani
ZDZach Dietch
Zach Dietch
DBDaniel Borja-Cacho
Daniel Borja-Cacho
RLRobert J. Lewandowski
Robert J. Lewandowski
Purpose: Hepatic artery stenosis is a recognized vascular complication after orthotopic liver transplantation, and endovascular treatment is technically demanding because of variable post-surgical anatomy. Augmented and virtual reality (AR/VR) allows immersive review of patient-specific three-dimensional imaging, but its clinical application to transplant hepatic artery interventions remains poorly described. This study evaluated the feasibility, usability, and perceived impact of AR/VR for preprocedural planning and intraprocedural guidance in transplant hepatic artery (HA) stenting. Methods: This IRB-approved single-center pilot study included eight consecutive patients undergoing transplant HA stenting from January 2025 to May 2026. Preprocedural planning was performed using an AR/VR headset and spatial computing software. In the final three cases, AR was used intraprocedurally to display live fluoroscopy during the procedure. Postprocedure surveys assessed workflow integration, anatomic visualization, confidence, usability, and comfort using 5-point Likert scales. Results: Cases were emergent in 12.5% and elective in 87.5%; 62.5% were high complexity. All cases were technically successful without major complications. Median case, fluoroscopy, and AR/VR planning times were 159.5, 34.8, and 4.5 min, respectively; median air kerma was 678 mGy. AR/VR planning represented 3.6% of case time and was perceived to change the approach in 6/8 cases (75%). Visualization, workflow integration, confidence, and anatomic understanding each received median scores of 5. Headset comfort was lowest-rated. Intraprocedural AR was successful in all 3 cases. Conclusion: AR/VR planning for transplant HA stenting is feasible, influencing procedural strategy in 75% of cases with maximum operator ratings for visualization, confidence, and workflow integration. Intraprocedural AR during transradial access was feasible.